Russell Investments Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$720M Buy
789,744
+123,276
+18% +$125M 0.77% 12
2025
Q4
$717M Buy
666,468
+79,570
+14% +$76.1M 0.78% 12
2025
Q3
$445M Buy
586,898
+29,188
+5% +$21.7M 0.5% 19
2025
Q2
$434M Sell
557,710
-97,917
-15% -$76.1M 0.55% 17
2025
Q1
$541M Sell
655,627
-68,889
-10% -$57.3M 0.74% 13
2024
Q4
$559M Buy
724,516
+61,998
+9% +$51.3M 0.77% 13
2024
Q3
$586M Buy
662,518
+84,310
+15% +$75.8M 0.85% 11
2024
Q2
$524M Buy
578,208
+7,802
+1% +$6.24M 0.84% 10
2024
Q1
$444M Buy
570,406
+53,602
+10% +$38.1M 0.7% 12
2023
Q4
$301M Buy
516,804
+8,309
+2% +$4.85M 0.54% 19
2023
Q3
$274M Buy
508,495
+33,377
+7% +$17.2M 0.54% 20
2023
Q2
$222M Sell
475,118
-38,910
-8% -$16.3M 0.43% 30
2023
Q1
$176M Buy
514,028
+52,836
+11% +$17.8M 0.35% 45
2022
Q4
$169M Buy
461,192
+18,214
+4% +$6.46M 0.35% 44
2022
Q3
$144M Sell
442,978
-2,469
-0.6% -$782K 0.32% 49
2022
Q2
$144M Buy
445,447
+20,790
+5% +$6.24M 0.29% 55
2022
Q1
$122M Sell
424,657
-30,380
-7% -$7.82M 0.21% 93
2021
Q4
$126M Buy
455,037
+51,730
+13% +$13.1M 0.2% 99
2021
Q3
$93.1M Buy
403,307
+11,226
+3% +$2.77M 0.16% 144
2021
Q2
$90M Buy
392,081
+16,627
+4% +$3.34M 0.15% 147
2021
Q1
$70.1M Sell
375,454
-327,401
-47% -$64M 0.12% 180
2020
Q4
$118M Sell
702,855
-846
-0.1% -$126K 0.23% 76
2020
Q3
$104M Buy
703,701
+145,227
+26% +$22.5M 0.22% 81
2020
Q2
$91.5M Buy
558,474
+55,992
+11% +$8.59M 0.2% 99
2020
Q1
$69.7M Buy
502,482
+169,278
+51% +$23.3M 0.18% 118
2019
Q4
$43.8M Buy
333,204
+10,264
+3% +$1.19M 0.08% 288
2019
Q3
$36.1M Sell
322,940
-88,106
-21% -$9.81M 0.07% 333
2019
Q2
$45.6M Sell
411,046
-48,814
-11% -$5.75M 0.09% 285
2019
Q1
$59.6M Sell
459,860
-240,341
-34% -$29.2M 0.11% 204
2018
Q4
$80.8M Sell
700,201
-206,639
-23% -$23.1M 0.18% 112
2018
Q3
$97.2M Buy
906,840
+188,150
+26% +$18.8M 0.18% 105
2018
Q2
$61.4M Buy
718,690
+17,955
+3% +$1.47M 0.13% 161
2018
Q1
$54.1M Buy
700,735
+100,928
+17% +$8.13M 0.09% 259
2017
Q4
$51M Sell
599,807
-277,911
-32% -$23.6M 0.09% 275
2017
Q3
$75.1M Buy
877,718
+206,391
+31% +$16.9M 0.13% 182
2017
Q2
$55.3M Buy
671,327
+48,706
+8% +$3.97M 0.1% 244
2017
Q1
$52.4M Sell
622,621
-94,980
-13% -$7.61M 0.1% 252
2016
Q4
$52.8M Buy
+717,601
New +$53.4M 0.1% 222

Other funds holding LLY

Russell Investments Group's LLY Position: Q1 2026 in Review

Russell Investments Group increased its Eli Lilly (LLY) stake by 18% in Q1 2026, buying an estimated $125M and bringing the position to 789,744 shares worth $720M. The position accounts for 0.77% of the portfolio, ranked #12.

Russell Investments Group first reported a position in LLY in Q4 2016 and has held it in 38 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Russell Investments Group held 789,744 shares of Eli Lilly worth $720M as of Q1 2026.
  • Russell Investments Group bought 123,276 Eli Lilly shares in Q1 2026, an estimated $125M.
  • Eli Lilly made up 0.77% of Russell Investments Group's portfolio in Q1 2026, its #12 holding.
  • Russell Investments Group first reported a position in Eli Lilly in Q4 2016 and has held it in 38 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.